Savant Capital LLC Has $3.81 Million Position in CVS Health Corporation $CVS

Savant Capital LLC cut its position in shares of CVS Health Corporation (NYSE:CVS) by 47.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 55,255 shares of the pharmacy operator’s stock after selling 50,855 shares during the quarter. Savant Capital LLC’s holdings in CVS Health were worth $3,811,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Avion Wealth increased its position in shares of CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the period. Harbor Asset Planning Inc. acquired a new stake in CVS Health during the second quarter worth $30,000. Bell Investment Advisors Inc increased its holdings in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the period. Roxbury Financial LLC raised its stake in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares in the last quarter. Finally, ORG Partners LLC lifted its holdings in shares of CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of NYSE CVS opened at $79.00 on Monday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $85.15. The company has a market capitalization of $100.29 billion, a P/E ratio of 207.90, a P/E/G ratio of 0.87 and a beta of 0.60. The stock has a 50 day moving average of $77.15 and a 200-day moving average of $69.48. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. The company had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period last year, the firm earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Analysts Set New Price Targets

A number of analysts recently weighed in on CVS shares. Wall Street Zen cut shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Mizuho upped their price objective on CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a research note on Thursday, October 9th. Cowen restated a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Robert W. Baird upgraded shares of CVS Health from a “neutral” rating to an “outperform” rating and boosted their target price for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a report on Wednesday. Two analysts have rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $89.45.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 1.22% of the stock is owned by corporate insiders.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.